Genetesis Inc.
A multicenter observational data development registry collecting diagnostic measures via standard of care (SOC) cardiac PET in order gain a better understanding of how CardioFlux MCG may be used in the detection of coronary ischemia.
Coronary; Ischemic
CardioFlux Magnetocardiography
Study Type : | Observational |
Estimated Enrollment : | 300 participants |
Official Title : | A Registry of Cardiac PET and CardioFlux Magnetocardiography in Patients With Suspected Coronary Ischemia. |
Actual Study Start Date : | August 28, 2023 |
Estimated Primary Completion Date : | June 1, 2025 |
Estimated Study Completion Date : | December 31, 2025 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 40 Years |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Recruiting
Kettering Health
Kettering, Ohio, United States, 45429